Design, synthesis and biological evaluation of new endocannabinoid transporter inhibitors
作者:Marı́a L. López-Rodrı́guez、Alma Viso、Silvia Ortega-Gutiérrez、Christopher J. Fowler、Gunnar Tiger、Eva de Lago、Javier Fernández-Ruiz、José A. Ramos
DOI:10.1016/s0223-5234(03)00045-x
日期:2003.4
describe the synthesis and the in vitro evaluation of a series of arachidonic acid derivatives of general structure I as endocannabinoid transporter inhibitors. In addition, we report the first in vivo studies of the most potent derivative (4, UCM707) within this series. The majority of compounds studied are highly potent (IC(50)=24-0.8 micro M) and selective endocannabinoid uptake inhibitors with very
在本工作中,我们描述了一系列具有通用结构I作为内源性大麻素转运蛋白抑制剂的花生四烯酸衍生物的合成和体外评估。此外,我们报告了该系列中最有效的衍生物(4,UCM707)的首次体内研究。所研究的大多数化合物都是高效的(IC(50)= 24-0.8 micro M)和选择性的内源性大麻素吸收抑制剂,对脂肪酸酰胺水解酶(IC(50)= 30-113 micro M)或对于大麻素受体亚型1(CB(1)),大麻素受体亚型2(CB(2))和香草类受体亚型1(VR(1))(K(i)= 1000-10000 nM)。其中(5Z,8Z,11Z,14Z)-N-(fur-3-ylmethyl)icosa-5,8,11,14-tetraenamide(UCM707)表现为迄今为止描述的最有效的内源性大麻素转运蛋白抑制剂(IC( 50)= 0。8 micro M)并显示出对anandamide转运蛋白的增强效力,对C